Evidence map›Paper›PMID 29273785›Full record

ArticleScientific reports2017

Construction of engineered corpus cavernosum with primary mesenchymal stem cells in vitro.

Xiaoshuai Xie, Xiaohang Du, Kailin Li, Yuan Chen, Yong Guan, Xiaofei Zhao, Guangzhu Niu, Yun Luan, Denglu Zhang, Chao Sun and 13 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 1 pooled it
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 1 synthesis or guideline pooled it, 41 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Anchoring bias in mental arithmetic.Psychological research · 2024
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Secreted microRNAs in bone metastasis.Journal of bone and mineral metabolism · 2023
    Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 2 institutions in 1 country.

Xiaoshuai XieDepartment of Urology, The Second Hospital, Shandong University, Shandong, China.
Xiaohang DuDepartment of Urology, The Second Hospital, Shandong University, Shandong, China.
Kailin LiDepartment of Central Research Laboratory, The Second Hospital, Shandong University, Shandong, China.
Yuan ChenDepartment of Central Research Laboratory, The Second Hospital, Shandong University, Shandong, China.
Yong GuanDepartment of Urology, The Second Hospital, Shandong University, Shandong, China.
Xiaofei ZhaoDepartment of Central Research Laboratory, The Second Hospital, Shandong University, Shandong, China.
Guangzhu NiuDepartment of Urology, The Second Hospital, Shandong University, Shandong, China.
Yun LuanDepartment of Central Research Laboratory, The Second Hospital, Shandong University, Shandong, China.
Denglu ZhangDepartment of Central Research Laboratory, The Second Hospital, Shandong University, Shandong, China.
Chao SunDepartment of Central Research Laboratory, The Second Hospital, Shandong University, Shandong, China.
Guanghui ChengDepartment of Central Research Laboratory, The Second Hospital, Shandong University, Shandong, China.
Jue WangDepartment of Central Research Laboratory, The Second Hospital, Shandong University, Shandong, China.
Qian XinDepartment of Central Research Laboratory, The Second Hospital, Shandong University, Shandong, China.
Aibing XueDepartment of Urology, The Second Hospital, Shandong University, Shandong, China.
Peng WangKey Laboratory for Kidney Regeneration of Shandong Province, Shandong, China.
Feng KongDepartment of Central Research Laboratory, The Second Hospital, Shandong University, Shandong, China.
Xiaoli LiuDepartment of Kidney Transplantation, The Second Hospital, Shandong University, Shandong, China.
Hongwei WangDepartment of Kidney Transplantation, The Second Hospital, Shandong University, Shandong, China.
Yuqiang LiuDepartment of Urology, The Second Hospital, Shandong University, Shandong, China.
Chuan TianDepartment of Kidney Transplantation, The Second Hospital, Shandong University, Shandong, China.
Mingzhen YuanDepartment of Urology, The Second Hospital, Shandong University, Shandong, China. yuanmingzhen2005@126.com.
Shuangde LiuDepartment of Kidney Transplantation, The Second Hospital, Shandong University, Shandong, China. liushuangdechina@126.com.
Shengtian ZhaoShandong University, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Shandong, China. zhaoshengtian@sdu.edu.cn.
Second Hospital of Shandong University · CNAffiliated Hospital of Shandong University of Traditional Chinese Medicine · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Various methods have been used to reconstruct the penis. The objective of this study was to investigate the feasibility of constructing engineered corpus cavernosum with primary mesenchymal stem cells (MSCs) in a rabbit model in vitro. Acellular corporal matrices (ACMs) were obtained from adult rabbit penile tissues through an established decellularization procedure. MSCs were separated, purified, and then seeded on ACMs to construct engineered corpus cavernosum. The seeded ACMs were subsequently cultured in an incubator for 14 days. Histological analyses showed that MSCs seeded on the ACMs had proliferated and were well distributed. Detection of CD31, vWF, smooth muscle actin (SMA), and myosin protein as well as vWF and myosin mRNA revealed that the MSCs had differentiated into endothelial cells and smooth muscle cells. In addition, cell morphology of the engineered corpus cavernosum was directly observed by transmission electron microscopy. This study demonstrated that engineered corpus cavernosum could be successfully constructed using primary MSCs in vitro. This technology represents another step towards developing engineered corpus cavernosum in vitro.

Indexed as

AnimalsCell DifferentiationEndothelial CellsMaleMesenchymal Stem CellsMyocytes, Smooth MusclePenisRabbitsTissue Engineering

Identifiers

PMID29273785
PMCPMC5741727
OpenAlexW2778729612

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.